0001104659-21-048715.txt : 20210409
0001104659-21-048715.hdr.sgml : 20210409
20210409161616
ACCESSION NUMBER: 0001104659-21-048715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210408
FILED AS OF DATE: 20210409
DATE AS OF CHANGE: 20210409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Romano Sarah
CENTRAL INDEX KEY: 0001697536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 21818030
MAIL ADDRESS:
STREET 1: 271 WAVERLY OAKS ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 781-788-9043
MAIL ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
4
1
tm2112624-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-08
0
0001372514
EYEGATE PHARMACEUTICALS INC
EYEG
0001697536
Romano Sarah
C/O EYEGATE PHARMACEUTICALS, INC.
271 WAVERLEY OAKS ROAD, SUITE 108
WALTHAM
MA
02452
0
1
0
0
Chief Financial Officer
Common Stock
2021-04-08
4
F
0
180
4.94
D
23933
D
Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Sarah Romano
2021-04-09